Laboratories in North Dakota are certified as meeting the requirements of the Clinical Laboratory Improvement Amendments (CLIA) of 1988. Certification in the CLIA program allows for Medicare/Medicaid reimbursement for lab services in the nearly 900 entities in the state of North Dakota that do some type of lab test.
Laboratory Demographics Lookup
Rural Health Information Hub
The Rural Health Information Hub (RHIhub) is the nation's rural health information source. The website offers an online library, coverage of rural issues, state guides, toolkits, program models, and more. RHIhub provides customized assistance by phone or email and is funded by the Federal Office of Rural Health Policy. For more information follow this link:
Visit the Rural Health Information Hub website.
Clinical Laboratory Improvement Amendments (CLIA) Information
(Effective 1/29/2024)
| Type of Lab | Number of Specialties | Annual Test Volume | Certificate Fee | Compliance Fee |
| Waived | N/A | N/A | $248 | N/A |
| PPM | N/A | N/A | $297 | N/A |
| Certificate of Compliance | ||||
| Low Vol. A | N/A | Less than 2,000 | $223 | $446 |
| Schedule A | 3 or Fewer | 2,000-10,000 | $223 | $1,443 |
| Schedule B | 4 or More | 2,000-10,000 | $223 | $1,924 |
| Schedule C | 3 or Fewer | 10,001-25,000 | $639 | $2,406 |
| Schedule D | 4 or More | 10,001-25,000 | $654 | $2,827 |
| Schedule E | N/A | 25,001-50,000 | $966 | $3,249 |
| Schedule F | N/A | 50,001-75,000 | $1,635 | $3,670 |
| Schedule G | N/A | 75,001- 100,000 | $2,304 | $4,090 |
| Schedule H | N/A | 100,001- 500,000 | $3,032 | $4,512 |
| Schedule I | N/A | 500,001- 1,000,000 | $9,244 | $4,933 |
| Schedule J | N/A | Greater than 1,000,000 | $11,801 | $5,353 plus $421 foreach additional 500,000 tests |
| Certificate of Accreditation | Same as the Certificate of Compliance Laboratory | Fees are 5% of the above, plus the accrediting agencies fee | ||
| Certificate of Registration | N/A | N/A | $123 | N/A |
Place your Plan of Correction here. Step 1. Print this document and refer to these instructions when placing your plan of correction on the CMS-2567. Step 2. Photocopy the original deficiency list when you receive it. Make copies of the first few pages to practice printing your PoC when it is complete. When you are comfortable with the location of your PoC on the form, place the original deficiency list into your printer feed tray and print the final PoC onto the CMS 2567. Step 3. Remember to use the instructions for the completion of a plan of correction and include the five specific points that must be covered to be an acceptable plan of correction. Please Note The margins on this page have been set to allow you to use Microsoft WordÔ to place your plan of correction in this document and have the resulting product ready to be printed onto the CMS-2567 without reformatting. 03/6/11 This template uses 11-point font. You may use larger or smaller font if you choose. The deficiency is written in 11-point font. 06/21/11 When placing the completion date in the right-most column, hit your tab key once and you will be on the left edge of the PoC date column. Type the date as you want it to appear. This format will allow you the most space possible for typing your PoC and still allow the completion date to be aligned correctly in the last column. 05/24/11 You need only one completion date for each deficiency that is cited on the CMS-2567. The dates contained on this sample page have no significance and are for demonstration use only. 03/15/11 If you accidentally delete the margin settings for this template, they are included here so you can setup your word processor identical to this document. In addition, if you use other than Microsoft WordÔ as your word processor, the following settings should be universal for all processors on the market. Margins: Top = 2.7 inches Bottom = 1.7 inches Left = 4.8 inches Right = 1.1 inches Tab set = 2.7 inches If you have problems with this template call the Division of Health Facilities to get assistance with formatting your plan of correction. 701.328.2352 03/06/11 Step 4. When you have read these instructions, delete this information from this template and begin to insert your plan of correction. |
Guidelines for Certificate of Provider-Performed Microscopy Procedures (PPMP)
A Certificate of Provider-Performed Microscopy Procedures (PPMP) permits a laboratory to perform a limited list of moderate complexity tests, as well as any waived tests. No survey is required but may be conducted and compliance with CLIA regulations is required. The following criteria must be met:
- The laboratory must obtain a CLIA certificate and pay the $200 fee which authorizes the facility to perform only waived and PPMP tests for a period not to exceed two years.
- The PPMP procedures must be personally performed by one of the following practitioners:
- A physician during the patient's visit on a specimen obtained from his or her own patient or from a patient of a group medical practice of which the physician is a member or an employee.
- A midlevel practitioner, under the supervision of a physician or in independent practice authorized by the State, during the patient's visit on a specimen obtained from his or her own patient or from a patient of a clinic, group medical practice, or other health care provider of which the practitioner is a member or an employee.
- A dentist during the patient's visit on a specimen obtained from his or her own patient or from a patient of a group dental practice of which the dentist is a member or an employee.
- The laboratory director must meet the following requirements:
- Be a physician
- Be a midlevel practitioner
- Be a dentist
- The PPMP procedures are categorized as moderately complex.
- The primary instrument for performing the PPM procedures is a microscope, limited to a bright field or phase-contrast microscopy.
- The PPMP specimens are labile and a delay in performing the test could compromise the accuracy of the test result.
- Control materials are not available to monitor the entire testing process; but two levels of controls must be performed if available.
- Limited specimen handling or processing is required.
- The Physician, midlevel practitioner or dentist may perform one or more of the following procedures:
- All direct wet mount preparations for the presence or absence of bacteria, fungi, parasites or cellular element
- All potassium hydroxide (KOH)preparations
- Pinworm examinations
- Fern test
- Post-coital direct, qualitative examinations of vaginal or cervical mucous
- Urine sediment examinations
- Fecal leukocyte examination
- Qualitative semen analysis (limited to the presence or absence of sperm and detection of motility)
- Nasal smears for eosinophils
In addition, the laboratory may also perform any test classified as waived.
- The laboratory must verify the accuracy of PPMP test results at least twice a year.
- The laboratory must meet all the applicable requirements of participation in proficiency testing, patient test management, quality control and quality assurance.
--For waived testing, the laboratory must follow the manufacturer’s instructions.--
Out of State Laboratories
North Dakota follows the federal CLIA regulations. A North Dakota laboratory must refer specimens for testing only to a CLIA certified laboratory. In order for an out of state reference laboratory to test specimens from North Dakota, the out of state laboratory must have the appropriate CLIA certificate. North Dakota does not license laboratories or laboratory directors. Facilities that only collect specimens do not need to be licensed or certified in our state.
GOOD LABORATORY PRACTICES
The Package Insert--IMPORTANT INFORMATION FOR EVERYONE
Tiny print, multiple pages…who has the time to read that?!?
It’s good lab practice to read the package insert. If you are evaluating tests to run in your lab, you’ll want to read the entire insert. If you have established tests, you should read at least the following sections each time you open a new box. Check to make sure you have the most current version of the package insert so that you will be following the most current version of the instructions. To check the version, look on the last page of the insert and check the date. Make sure you have the most current date.
Intended Use
This section describes what the test will detect. It informs the tester what sample is needed for the test,
e.g. urine, throat swab, whole blood, etc.
Specimen Collection and Preparation
Instructions on obtaining a proper sample, and how that sample should be preserved and transported for that particular test. Useful and accurate results come only from correct specimens.
Storage Requirements or Stability
The temperature range for proper storage of the reagents is found in this section. Expiration information will also be listed here.
Procedure
Explicit step by step instructions are presented here. Exactly following the procedures developed by the manufacturer is the only way to get accurate and meaningful test results. You will find important warnings, acceptable procedures and disposal information in this section.
Quality Control
This is a very important section. It contains instructions regarding the use of quality control (QC) material and the frequency of QC testing. You must follow the procedures exactly to ensure the testing process is working.
Interpretation of Results
This section has explicit detail on how to read and interpret the test results.
Limitation of Procedures
The test only works within certain prescribed situations. There are limits to accurate test results. Make sure your results and testing procedures are within manufacturer’s specifications. Certain factors, called interfering substances, will prevent the test from performing correctly. Be aware of the circumstances that will give false results that may lead to incorrect treatment of the patient.
Don’t forget the manufacturer’s telephone number!
Often a toll-free number, keep it handy for technical assistance if the need arises.
- Keep the manufacturer’s product insert for the laboratory test in use and be sure it is available to the testing personnel. Use the manufacturer’s product insert for the kit currently in use; do not use old product inserts.
- Follow the manufacturer’s instructions for specimen collection and handling.
- Are specimens stored at the proper temperature?
- Are the appropriate collection containers used?
- Be sure to properly identify the patient.
- Does the name on the test requisition (or prescription) match the patient’s name?
- Does the name on the patient’s chart match the name on the patient’s identification?
- If more than one patient is present with the same first and last name, how do you determine which one is the test patient? (Look for possible gender differences, social security number, patient identification number, birthdates, different middle name, and relevance of the test to the patient’s history).
- Be sure to label the patient’s specimen for testing with an identifier unique to each patient.
- Inform the patient of any test preparation such as fasting, clean catch urines, etc.
- Read the product insert prior to performing a test.
- Become familiar with the test procedure.
- Study each step and perform them in the proper order.
- Know the time required for performing the test and achieving the optimal result.
- Be sure to have all of the required reagents and equipment ready before actually performing the test.
- Be able to recognize when the test is finished – e.g. will there be a blue plus or minus sign against a white background?
- Follow the manufacturer’s instructions and when a new kit is opened, perform the quality control to be sure that the kit works prior to testing patient samples.
- Follow the storage requirements for the test kit. If the kit can be stored at room temperature but this changes the expiration date, write the new expiration date on the kit.
- Do not mix components of different kits!
- Record the patients’ test results in the proper place, such as the patient’s chart or the laboratory test log, but not on unidentified post-it notes or pieces of scrap paper that can be misplaced.
- Record the results according to the instructions in the manufacturer’s product insert.
- If it’s a qualitative test, spell out positive/negative or pos/neg because symbolic representations can be altered (the – can be altered to a +).
- Include the name of the test, the date the test was performed, and the initials of the testing personnel in the test record. Include the calendar year in the date.
- If the same test is performed on a patient multiple times in one day, include the time of each test.
- Perform any instrument maintenance as directed by the manufacturer.
- CLIA means the Clinical Laboratory Improvement Amendments of 1988.
- Certificate of waiver (COW) allows a facility to do only waived tests.
- PPMP Certificate allows qualified providers to do waived testing and certain microscopic examinations during the patients’ visit.
- Certificate of registration or registration certificate means a certificate issued to a laboratory that enables the entity to conduct moderate or high complexity laboratory testing or both until the entity is determined to be in compliance through a survey by the Centers for Medicare and Medicaid Services (CMS) or its agent; or in accordance with Sec. 493.57 to an entity that is accredited by an approved accreditation organization.
- HHS means the Department of Health and Human Services, or its designee.
- Kit means all components of a test that are packaged together.
- Laboratory means a facility for the examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered laboratories.
- MedWatch: FDA service for health care facilities to voluntarily report a serious adverse event or product problem that the user suspects is associated with a drug or medical device used, prescribed, or dispensed.
Online: www.fda.gov/medwatch/report/hcp.htm Phone: 1-800-FDA-1088
- A pipet/pipette is a narrow, usually calibrated glass or plastic tube into which small amounts of liquid are suctioned for transfer or measurement.
- Plasma is the usually clear, yellowish fluid portion of blood, lymph, or intramuscular fluid in which cells are suspended. It is the fluid produced when a blood specimen is collected in a vacuum tube with anticoagulant.
- Serum is the usually clear yellowish fluid obtained upon separating whole blood into its solid and liquid components after it has been allowed to clot. Also called blood serum.
- A reagent is a substance or material or ingredient used in a lab test to detect, measure, examine, or produce other substances.
- Controls are materials with known values of the substance measured that help the laboratory achieve accurate and reliable testing by checking if the test system is working. Controls, also known as quality control material, are external or internal. External controls are usually a liquid and are processed or tested in the same manner as a patient specimen. Internal or procedural controls are indicators that the test procedure was performed in the proper order.
- Quality Control (QC) procedures help to ensure the excellence of the patient testing. If the QC results are not within the prescribed range or the expected pattern, then the laboratory cannot be sure that the patients test results are accurate and reliable. See Controls above.
- Quality Assessment (QA) is the laboratory’s self-examination of the specimen collection, testing, and test reporting processes. What does the laboratory do to assure accurate results? Ten recommended QA questions to ask are:
- Are the patients and specimens properly identified?
- Are the patients’ charts up-to-date with the proper patient test information?
- Is the quality control performed and documented?
- Did the laboratory get the right answers for the quality control?
- Do the waived test results correlate with the patients’ history or symptoms?
- Are there any complaints about the laboratory testing?
- Are the testing personnel trained prior to performing laboratory testing?
- Are there periodic discussions about laboratory concerns?
- Screening tests – initial tests to determine if a disease or medical condition exists.
- Diagnostic tests – tests to identify a disease or medical condition that exists in a patient.
- Monitoring tests – once a patient is diagnosed with a disease or medical condition, these tests help the clinician keep track of the patient’s specific medical condition or response to treatment on a periodic basis.
Routine order of draw (when the laboratory collects more than one tube of blood at a time on a patient):
- Blood culture tube
- Non-additive serum tube
- Citrate tube
- SST (serum separator tube), plastic serum tube
- Heparin tube
- EDTA tube
- Glycolytic inhibitor tube
Please consult with the reference laboratory for specific specimen collection requirements.
Package Insert – Instructions included by the manufacturer in the kit or test package. Read these carefully each time a new kit is opened to check for changes in procedures or quality control. Retain the current package insert for reference. The language used to convey the instructions is important. Words like ‘always’, ‘shall’, ‘must’, ‘test’, ‘perform’, ‘do’ and ‘required’ mean the instruction is regulatory and must be performed. ‘Should’ or ‘recommend’ mean the action is not regulatory, but it is good laboratory practice to perform those actions.
NOTE: THIS DOCUMENT IS INTENDED AS A PRELIMINARY EDUCATION TOOL FOR LABORATORIES THAT HAVE A CLIA CERTIFICATE OF WAIVER. THE STATEMENTS ARE RECOMMENDATIONS THAT MAY HELP TO IMPROVE THE QUALTIY OF LABORATORY TESTING. ADHERENCE TO THIS DOCUMENT IS VOLUNTARY AND IS NOT CONSIDERED TO BE ALL INCLUSIVE. FOR A MORE COMPREHENSIVE MODEL OF GOOD LABORATORY PRACTICES, READ THE ARTICLE “GOOD LABORATORY PRACTICES FOR WAIVED TESTING SITES” IN THE MORBIDITY AND MOTRALITY WEEKLY REPORT (MMWR) WHICH IS AVAILABLE ON THE INTERNET AT
CLIA INFORMATION IS AVAILABLE ON THE INTERNET AT http://www.cms.hhs.gov/clia/
11-02-2009